Impact of the Ki-67 proliferation index on response to peptide receptor radionuclide therapy (Q85050851)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852858%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Impact of the Ki-67 proliferation index on response to peptide receptor radionuclide therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852858%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852858%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Samer Ezziddin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852858%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Martin Opitz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852858%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Mared Attassi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852858%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Kim Biermann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852858%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Amir Sabet

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852858%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Stefan Guhlke

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852858%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Holger Brockmann

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852858%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Winfried Willinek

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852858%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Eva Wardelmann

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852858%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Hans-Jürgen Biersack

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852858%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

18 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852858%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Nuclear Medicine and Molecular Imaging

14 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852858%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852858%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852858%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

459-466

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852858%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00259-010-1610-2

14 February 2020

exact match

0 references

cites work

TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

1 reference

12 December 2020

Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors.

1 reference

12 December 2020

The addition of DTPA to [177Lu-DOTA0,Tyr3]octreotate prior to administration reduces rat skeleton uptake of radioactivity

1 reference

12 December 2020

Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival

1 reference

12 December 2020

[PET-CT for neuroendocrine tumors and nuclear medicine therapy options].

1 reference

12 December 2020

Chemotherapy and role of the proliferation marker Ki-67 in digestive neuroendocrine tumors

1 reference

12 December 2020

Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours

1 reference

12 December 2020

Factors predicting tracer uptake in somatostatin receptor and MIBG scintigraphy of metastatic gastroenteropancreatic neuroendocrine tumors.

1 reference

12 December 2020

Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors

1 reference

12 December 2020

Prognostic factors in gastrointestinal endocrine tumors

1 reference

12 December 2020

Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG.

1 reference

12 December 2020

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: peptide receptor radionuclide therapy with radiolabeled somatostatin analogs

1 reference

12 December 2020

TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system.

1 reference

12 December 2020

Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours

1 reference

12 December 2020

Optimising conditions for radiolabelling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities

1 reference

12 December 2020

Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria

1 reference

12 December 2020